Órgano oficial de Instituto Panvascular de Occidente, S.C.
Alternativas de Mmanejo a la Hipoxemia Refractaria en Paciente COVID-19: Revisión de la Literatura
PDF Artículo de Revisión

Palabras clave

Oxigenación
Riesgo
Soporte
Ventilación

Categorías

Cómo citar

1.
Dulcey Sarmiento LA, Theran-León JS, Caltagirone R, Castillo-Blanco JF. Alternativas de Mmanejo a la Hipoxemia Refractaria en Paciente COVID-19: Revisión de la Literatura. Rev Med Clin [Internet]. 21 de abril de 2022 [citado 26 de junio de 2022];6(1):321042206007. Disponible en: https://medicinaclinica.org/index.php/rmc/article/view/384

Resumen

Introducción: La pandemia por COVID-19 ha creado un desafío nunca antes visto en los sistemas de salud generando una carga que ha venido creciendo exponencialmente. Objetivo: El objetivo principal de esta revisión es conocer las indicaciones de dicha terapia ya que las dos principales causas de muerte en este proceso patológico son la hipoxemia que no responde asociada al distrés respiratorio y el choque con sus subsecuentes fallos multiorgánicos. Métodos: Se realizó una revisión de la literatura reciente sobre el soporte con membrana extracorpórea el cual se ha utilizado en pacientes con fallo ventilatorio que no responden al manejo en decúbito prono y con parámetros adecuados. Resultados: Es muy poca la evidencia científica disponible hasta el momento dado que son muy pocos los grupos expertos en el área de dicho soporte, sin embargo, se encontró en la revisión que existe indicación formal de dicho soporte en pacientes con COVID-19 que no respondan a las medidas de manejo tradicional. Conclusión: El soporte con membrana extracorpórea ha surgido como una alternativa para tener en cuenta en el escalafón de medidas terapéuticas en pacientes que no responden a manejo tradicional, estos pacientes deben ser muy rigurosamente seleccionados buscando prolongar la supervivencia.

https://doi.org/10.5281/zenodo.6475671
PDF Artículo de Revisión

Citas

Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. Roca O, Messika J, Caralt B, García-de-Acilu M, Sztrymf B, Ricard JD, Masclans JR. J Crit Care. 2016 Oct;35:200-5. doi: 10.1016/j.jcrc.2016.05.022. Epub 2016 May 31. PMID: 27481760

An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, García-de-Acilu M, Frat JP, Masclans JR, Ricard JD. Am J Respir Crit Care Med. 2019 Jun 1;199(11):1368-1376. doi: 10.1164/rccm.201803-0589OC. PMID: 30576221

Cumming M, Baldwin M, Abrams C, Jocobson S, Meyer B, BaloughE, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763---70.

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics comorbidities, and outcomes among 5700 patients hospitalized with COVID-19in the New York City Area. JAMA. 2020;323:2052---9.

Combes A, Pellegrino V. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1)-associated acute respiratory distress syndrome. Semin Respir Crit Care Med. 2011;32:188---94.6.

Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multi-center randomized controlled trial. Lancet. 2009;374:1351---63,http://dx.doi.org/10.1016/S0140-6736(09)61069-2.7.

Zwischenberger JB, Lynch JE. Will CESAR answer the adult ECMO debate? Lancet. 2009;374:1307---8,http://dx.doi.org/10.1016/S0140-6736(09)61630-5.8

Alshahrani MS, Sindi A, Alshamsi F, Al-Omari A, el Tahan M, Alah-madi B, et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care. 2018;8:3, http://dx.doi.org/10.1186/s13613-017-0350-x.

Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, et al., EOLIA Trial Group, REVA, and ECMONet. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378:1965---75.

Goligher EC, Tomlinson G, Hajage D, Wijey sundera DN, Fan E, Jüni P, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial. JAMA. 2018;320:2251---9.

Munshi L, Walkey A, Goligher E, Pham T, Uleryk EM, Fan E.Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med. 2019;7:163---72.

ECMOnet-Japan C-19. Japan ECMOnet for COVID-19: telephone consultations for cases with severe respiratory failure caused by COVID-19. J Intensive Care. 2020;8:24.

Jung H, Lim J, Kang SH, Kim SG, Lee Y, Lee J, et al. Outcomes of COVID-19 among patients on in-center hemodialysis: An experience from the epicenter in South Korea. J Clin Med.2020;9: E1688.

Zeng Y, Cai Z, Xianyu Y, Yang BX, Song T, Yan Q. Prognosis when using extracorporeal membrane oxygenation (ECMO) for criti-cally ill COVID-19 patients in China: A retrospective case series. Crit Care. 2020;24:8---10.

Jacobs JP, Stammers AH, St Louis J, Hayanga JWA, Firstenberg MS, Mongero LB, et al. Extracorporeal membrane oxygenation in the treatment of severe pulmonary and cardiac compromise in COVID-19: Experience with 32 patients. ASAIO J.2020;66:722---30.

Marullo AG, Cavarretta E, Biondi Zoccai G, Mancone M, Peruzzi M, Piscioneri F, et al. Extracorporeal membrane oxygenation for critically ill patients with coronavirus-associated disease 2019: an updated perspective of the European experience. Minerva Cardio angiol. 2020,http://dx.doi.org/10.23736/S0026-4725.20.05328-1

Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369:2126---36.

Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as com-pared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med.2000;342:1301---8.

Amato MBP, Meade MO, Slutsky AS, Brochard L, Costa ELV, Schoenfeld DA, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372:747---55.

Alhazzani W, Alshahrani M, Jaeschke R, Forel JM, Papazian L, Sevransky J, et al. Neuromuscular blocking agents in acute respiratory distress syndrome: A systematic review and meta-analysis of randomized controlled trials. Crit Care. 2013;17:R43,http://dx.doi.org/10.1186/cc12557.

Moss M, Huang DT, Brower RG, Ferguson ND, Ginde AA, Gong MN, et al. Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med. 2019;380:1997---2008

Munshi L, del Sorbo L, Adhikari NKJ, Hodgson CL, Wunsch H, Meade MO, et al. Prone position for acute respiratory distress syndrome: A systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14 Suppl. 4:S280---8

Chang T, Wu J, Chang L. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475---81

Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, De Boisblanc B, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564---75.

Goligher EC, Hodgson CL, Adhikari NKJ, Meade MO, Wunsch H, Uleryk E, et al. Lung recruitment maneuvers for adult patients with acute respiratory distress syndrome: A systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14 Supl.4r: S304---11.

Amato MBP, Meade MO, Slutsky AS, Brochard L, Costa ELV, Schoenfeld DA, et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015;372:747---55.

Juma S, Taabazuing MM, Montero-Odasso M. Clinical frailty scale in an acute medicine unit: A simple tool that predicts length of stay. Can Geriatr J. 2016;19:34---9.35.

Prekker ME, Brunsvold ME, Bohman JK, Fischer G, Gram KL, Litell JM, et al. Regional planning for extracorporeal membrane oxygenation allocation during COVID-19. Chest. 2020;158:603---7,http://dx.doi.org/10.1016/j.chest.2020.04.026.39.

Haye G, Fourdrain A, Abou-Arab O, Berna P, Mahjoub Y. COVID-19 outbreak in France: Setup and activities of a mobile extra corporeal membrane oxygenation (ECMO) team during the first 3 weeks. J Cardiothorac Vasc Anesth. 2020,http://dx.doi.org/10.1053/j.jvca.2020.05.004.

Prekker ME, Brunsvold ME, Bohman JK, Fischer G, Gram KL, Litell JM, et al. Regional planning for extracorporeal membrane oxygenation allocation during COVID-19. Chest. 2020;158:603---7,http://dx.doi.org/10.1016/j.chest.2020.04.026.

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

Derechos de autor 2022 Revista de Medicina Clínica